West syndrome is an age-related specific epileptic encephalopathy due to multiple and diverse causes. It is characterized by a unique type of seizure called epileptic (infantile) spasms and gross EEG abnormalities of hypsarrhythmia. Usually, West syndrome consists of a characteristic triad: infantile spasms, the arrest of psychomotor development, and hypsarrhythmia, although one element may be missing. Spasms may be flexor, extensor, lightning, or nods, but most commonly they are mixed. Onset peaks are observed between the ages of 4-7 months and always occur before the age of 1 year. Also, boys are more commonly affected, and the prognosis is generally poor.
This report contains market size and forecasts of West Syndrome in Global, including the following market information:
Global West Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global West Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Treatment Practices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of West Syndrome include GW Pharmaceuticals, Lundbeck, Mallinckrodt Pharmaceuticals, INSYS Therapeutics, Questcor Pharmaceuticals and BioPharm Solutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the West Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global West Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global West Syndrome Market Segment Percentages, by Type, 2021 (%)
Treatment Practices
Emerging Drugs
Global West Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global West Syndrome Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global West Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global West Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies West Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies West Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GW Pharmaceuticals
Lundbeck
Mallinckrodt Pharmaceuticals
INSYS Therapeutics
Questcor Pharmaceuticals
BioPharm Solutions